Publication:
International initiative for a curated variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma.

dc.contributor.authorBen Aim, Laurene
dc.contributor.authorMaher, Eamonn R
dc.contributor.authorCascon Soriano, Alberto
dc.contributor.authorBarlier, Anne
dc.contributor.authorGiraud, Sophie
dc.contributor.authorErcolino, Tonino
dc.contributor.authorPigny, Pascal
dc.contributor.authorClifton-Bligh, Roderick J
dc.contributor.authorMirebeau-Prunier, Delphine
dc.contributor.authorMohamed, Amira
dc.contributor.authorFavier, Judith
dc.contributor.authorGimenez-Roqueplo, Anne-Paule
dc.contributor.authorSchiavi, Francesca
dc.contributor.authorToledo, Rodrigo A
dc.contributor.authorDahia, Patricia L
dc.contributor.authorRobledo Batanero, Mercedes
dc.contributor.authorBayley, Jean Pierre
dc.contributor.authorBurnichon, Nelly
dc.contributor.funderCancer Research for PErsonalized Medicine (CARPEM)
dc.contributor.funderEuropean Research Council (ERC)
dc.contributor.funderNational Institutes of Health Research (NIHR)
dc.contributor.funderNational Institutes of Health (NIH)-National Institute of General Medical Science (NIGMS)
dc.contributor.funderNIH-National Center for Advancing Translational Science (NCATS) Clinical Translational Science Award (CTSA)
dc.contributor.funderMays Cancer Center NIH-National Cancer Institute (NCI)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.date.accessioned2025-01-23T11:51:33Z
dc.date.available2025-01-23T11:51:33Z
dc.date.issued2022-08
dc.description.abstractis one of the major genes predisposing to paraganglioma/pheochromocytoma (PPGL). Identifying pathogenic variants in patients with PPGL is essential to the management of patients and relatives due to the increased risk of recurrences, metastases and the emergence of non-PPGL tumours. In this context, the 'NGS and PPGL (NGSnPPGL) Study Group' initiated an international effort to collect, annotate and classify variants and to provide an accurate, expert-curated and freely available variant database.
dc.description.abstractA total of 223 distinct variants from 737 patients were collected worldwide. Using multiple criteria, each variant was first classified according to a 5-tier grouping based on American College of Medical Genetics and NGSnPPGL standardised recommendations and was then manually reviewed by a panel of experts in the field.
dc.description.abstractThis multistep process resulted in 23 benign/likely benign, 149 pathogenic/likely pathogenic variants and 51 variants of unknown significance (VUS). Expert curation reduced by half the number of variants initially classified as VUS. Variant classifications are publicly accessible via the Leiden Open Variation Database system (https://databases.lovd.nl/shared/genes/SDHB).
dc.description.abstractThis international initiative by a panel of experts allowed us to establish a consensus classification for 223 variants that should be used as a routine tool by geneticists in charge of PPGL laboratory diagnosis. This accurate classification of genetic variants will help to clarify the diagnosis of hereditary PPGL and to improve the clinical care of patients and relatives with PPGL.
dc.description.peerreviewed
dc.description.tableofcontentsThis work was supported in part by a salary grant to NB from Cancer Research for PErsonalized Medicine (CARPEM). ERM acknowledges funding from the European Research Council (Advanced Researcher Award), NIHR (Senior Investigator Award and Cambridge NIHR Biomedical Research Centre) and Cancer Research UK Cambridge Cancer Centre. The University of Cambridge has received salary support in respect of ERM from the NHS in the East of England through the Clinical Academic Reserve. PLD receives support from the National Institutes of Health (NIH)-National Institute of General Medical Science (NIGMS) GM114102, NIH-National Center for Advancing Translational Science (NCATS) Clinical Translational Science Award (CTSA) UL1 TR001120 and UL1 TR002645, the Mays Cancer Center NIH-National Cancer Institute (NCI) P30 CA54174, Alex's Lemonade Childhood Foundation, with support from Northwest Mutual and Flashes of Hope, and University of Texas Health SystemSTARS Award. RAT holds a Miguel Servet-I research contract by Institute of Health Carlos III (ISCIII) of the Ministry of Economy (CP17/00199) and Competitiveness; is supported by an Olga Torres Foundation Emerging researcher grant and by the Swiss Bridge Award for cancer immunotherapy research; and received research grants from BeiGene, Novartis and AstraZeneca. Cancer Genetics, Kolling Institute, Sydney acknowledges support from the Hillcrest Foundation (Perpetual Trustees). JPB in Leiden, The Netherlands acknowledges support from the Paradifference Foundation. MR is supported by the Instituto de Salud Carlos III (ISCIII), Accion Estrategica en Salud, cofounded by FEDER (grant number PI17/01796).
dc.format.number8
dc.format.page785-792
dc.format.volume59
dc.identifier.citationJ Med Genet . 2022 Aug;59(8):785-792.
dc.identifier.journalJournal of Medical Genetics
dc.identifier.pubmedID34452955
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26114
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F01796/ES/MECANISMOS ASOCIADOS A PROGRESION DE TUMORES ENDOCRINOS Y NEUROENDOCRINOS/
dc.relation.projectIDCP17/00199
dc.relation.publisherversionhttp://doi: 10.1136/jmedgenet-2020-107652.
dc.repisalud.institucionCNIO
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Cáncer Endocrino Hereditario
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectadrenal gland diseases
dc.subjectdatabases
dc.subjectgenetic
dc.subjectgenetic testing
dc.subjectgenetic variation
dc.subjecthuman genetics
dc.titleInternational initiative for a curated variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication610499dd-7ca3-4e9a-8b44-e5489f9212ab
relation.isAuthorOfPublicatione5c716e0-8396-45cb-a653-686569945266
relation.isAuthorOfPublication.latestForDiscovery610499dd-7ca3-4e9a-8b44-e5489f9212ab
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
internationalinitiative-2020.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format